Menu

Baycol

On August 24th, 2001 a proposed class action was commenced against Bayer Inc. (“Bayer”) arising out of that company’s marketing of the cholesterol-lowering drug known alternatively as Baycol, Cervastatin or Lipobay (“Baycol”).

Counsel for the proposed class action were Branch MacMaster, Hanson Wirsig Matheos and Joseph M. Prodor.

Would you like to get in touch
with our lawyers?

Contact Us